Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 34Terminated 8Recruiting 7Active not recruiting 6Unknown 4Withdrawn 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 27Carcinoma, Non-Small-Cell Lung 15Neoplasms 6Lung Neoplasms 6Cholangiocarcinoma 6Carcinoma, Hepatocellular 5Sarcoma 4Neoplasm Metastasis 4Bone Neoplasms 4Recurrence 3Ovarian Neoplasms 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma 3Histiocytoma, Malignant Fibrous 3Dermatofibrosarcoma 3Biliary Tract Neoplasms 3Adenocarcinoma 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Sarcoma, Synovial 2Rhabdomyosarcoma 2Neoplasms, Unknown Primary 2Lymphoma, T-Cell 2Lymphoma, B-Cell 2Liposarcoma 2Leiomyosarcoma 2Hodgkin Disease 2Hemangiosarcoma 2Gallbladder Neoplasms 2Fallopian Tube Neoplasms 2

Interventions

Gemcitabine 2Capecitabine 2galactomannan 1Sevoflurane 1Phototherapy 1Photochemotherapy 1Pharmacogenomic Testing 1Oxaliplatin 1MK 2206 1Laser Therapy 1Irinotecan 1IMC-001 1Fluorouracil 1Dihematoporphyrin Ether 1Desflurane 1Cisplatin 1Chemotherapy, Adjuvant 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Gallbladder Neoplasms × Gemcitabine × Clear all
NCT03579758 2020-06-05

Chemotherapy Before & After Surgery in Patients With Resectable Gallbladder Cancer

Emory University

Phase 3 Withdrawn
Gastrointestinal

Gallbladder Neoplasms

NCT02105350 2018-02-19

A Study of MEK162 With Gemcitabine and Oxaliplatin in Biliary Cancer

University Health Network, Toronto

Phase 1 Withdrawn
Gastrointestinal

Gallbladder Neoplasms, Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡